Seshadri Neervannan

Insider Reports History

Entity
Individual
Location
15440 Laguna Canyon Road, Suite 160, Irvine, CA
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Seshadri Neervannan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Common Stock 64.8K $1.98M $30.60 Mar 18, 2024 Direct
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Restricted Stock Units 24.4K $494K $20.22 Mar 15, 2024 Direct
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Stock Option (right to buy) 47.5K Mar 7, 2024 Direct

Insider Reports Filed by Seshadri Neervannan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARS Tarsus Pharmaceuticals, Inc. Mar 15, 2024 4 -$149K 4 Mar 19, 2024 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 7, 2024 2 $0 4 Mar 11, 2024 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 21, 2023 3 -$14.3K 4 Mar 23, 2023 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 17, 2023 2 -$9.57K 4 Mar 21, 2023 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 15, 2023 3 -$4.79K 4 Mar 17, 2023 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 8, 2023 2 $0 4 Mar 10, 2023 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 9, 2022 2 $0 4 Mar 11, 2022 Chief Operating Officer